Authors:
van Laar, JM
Verburg, RJ
Fibbe, WE
Breedveld, FC
Citation: Jm. Van Laar et al., Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: The Leiden experience, J RHEUMATOL, 28, 2001, pp. 25-27
Authors:
Verburg, RJ
Sont, JK
Vlieland, TPMV
Landewe, RB
Boers, M
Kievit, J
van Laar, JM
Citation: Rj. Verburg et al., High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis, J RHEUMATOL, 28(4), 2001, pp. 719-727
Authors:
Burt, RK
Fassas, A
Snowden, JA
van Laar, JM
Kozak, T
Wulffraat, NM
Nash, RA
Dunbar, CE
Arnold, R
Prentice, G
Bingham, S
Marmont, AM
McSweeney, PA
Citation: Rk. Burt et al., Collection of hematopoietic stem cells from patients with autoimmune diseases, BONE MAR TR, 28(1), 2001, pp. 1-12
Authors:
Verburg, RJ
Kruize, AA
van den Hoogen, FHJ
Fibbe, WE
Petersen, EJ
Preijers, F
Sont, JK
Barge, RMY
Bijlsma, JWJ
van de Putte, LB
Breedveld, FC
van Laar, JM
Citation: Rj. Verburg et al., High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis - Results of an open study to assess feasibility, safety, and efficacy, ARTH RHEUM, 44(4), 2001, pp. 754-760
Citation: Jm. Van Laar, Immune ablation and stem-cell therapy in autoimmune disease - Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation, ARTHRITIS R, 2(4), 2000, pp. 270-275
Citation: Jm. Van Laar et al., Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable?, RHEUMATOLOG, 39(6), 2000, pp. 680-681